Madrigal Pharmaceuticals (MIL:1MDGL) OCF Yield %: -2.27 (As of Jun. 29, 2026)


MIL:1MDGL Madrigal Pharmaceuticals Inc MIL:1MDGL
8 GF Score
Price €416.00
! 4 Warning Signs
View Full Analysis

What is Madrigal Pharmaceuticals OCF Yield %?

Madrigal Pharmaceuticals MIL:1MDGL 8 OCF Yield % is -2.27 as of Jun. 29, 2026. GuruFocus rates MIL:1MDGL with a GF Score™ of 8/100. The stock has 4 warning signs investors should review. Among 1,416 Biotechnology companies, Madrigal Pharmaceuticals ranks better than 69% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Madrigal Pharmaceuticals's Trailing 12-Month Cash Flow from Operations is €-231.6 Mil, and Market Cap is €10,403.4 Mil. Therefore, Madrigal Pharmaceuticals's OCF Yield % for today is -2.27%.

The historical rank and industry rank for Madrigal Pharmaceuticals's OCF Yield % or its related term are showing as below:

MIL:1MDGL' s OCF Yield % Range Over the Past 10 Years
Min: -9.87   Med: -4.47   Max: -1.19
Current: -2.27

During the past 13 years, the highest OCF Yield % of Madrigal Pharmaceuticals was -1.19%. The lowest was -9.87%. And the median was -4.47%.

MIL:1MDGL's OCF Yield % is ranked better than
69% of 1416 companies
in the Biotechnology industry
Industry Median: -8.23 vs MIL:1MDGL: -2.27

Madrigal Pharmaceuticals's OCF Margin % for the quarter that ended in Mar. 2026 was %.

Madrigal Pharmaceuticals OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Madrigal Pharmaceuticals OCF Yield % Related Terms

Madrigal Pharmaceuticals OCF Yield % Historical Data

* Premium members only.

The historical data trend for Madrigal Pharmaceuticals's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Madrigal Pharmaceuticals OCF Yield % Chart

Madrigal Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -1.42

Madrigal Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -2.83 3.19 -4.01 -5.72

MIL:1MDGL vs BMRN, AXSM, CYTK: OCF Yield % Comparison

For the Biotechnology subindustry, Madrigal Pharmaceuticals's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Madrigal Pharmaceuticals OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Madrigal Pharmaceuticals's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Madrigal Pharmaceuticals's OCF Yield % falls into.


MIL:1MDGL
8GF Score
Madrigal Pharmaceuticals Inc MIL:1MDGL
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Madrigal Pharmaceuticals OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Madrigal Pharmaceuticals's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-161.878 / 11382.1686
=-1.42%

Madrigal Pharmaceuticals's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-144.831 * 4 / 10122.3506
=-5.72%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -2.27 mean?
Madrigal Pharmaceuticals (MIL:1MDGL) has a OCF Yield % of -2.27 as of Jun. 29, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Madrigal Pharmaceuticals and its competitors. According to the industry distribution chart, Madrigal Pharmaceuticals ranks #439 out of 1416 companies in the Biotechnology industry, placing it in the top 31%.
Is Madrigal Pharmaceuticals' OCF Yield % too high?
Madrigal Pharmaceuticals' current OCF Yield % is -2.27. Based on the distribution chart, Madrigal Pharmaceuticals ranks #439 out of 1416 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Madrigal Pharmaceuticals has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Madrigal Pharmaceuticals' OCF Yield % compare to BMRN and AXSM?
According to the Biotechnology industry distribution chart, Madrigal Pharmaceuticals ranks #439 out of 1416 companies for OCF Yield %. This puts Madrigal Pharmaceuticals in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Madrigal Pharmaceuticals and its competitors. Madrigal Pharmaceuticals's current OCF Yield % is -2.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Madrigal Pharmaceuticals stock overvalued right now?
Madrigal Pharmaceuticals (MIL:1MDGL) has a current OCF Yield % of -2.27. The current OCF Yield % is -2.27. Madrigal Pharmaceuticals' overall GF Score™ is 8/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Madrigal Pharmaceuticals (MIL:1MDGL), the current OCF Yield % is -2.27 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Madrigal Pharmaceuticals Business Description

Other Exchanges MDGL:USA0JXI:UKYDO1:Germany
Address 200 Barr Harbor Drive, Suite 200, Four Tower Bridge, West Conshohocken, PA, USA, 19428
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
8GF Score

Get the complete analysis for MIL:1MDGL

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€416.00
Price